Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA approves Erbitux to treat late-stage head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux ( cetuximab ) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

REFINE

medications
- - Erbitux (1) Apply Erbitux filter
conditions
- - (-) Remove Cancer filter Cancer
    (-) Remove Nasal Cancer filter Nasal Cancer
    
    Esophageal Cancer (1) Apply Esophageal Cancer filter
    
    Oral Cancer (1) Apply Oral Cancer filter
    
    Thyroid Cancer (1) Apply Thyroid Cancer filter